Baxter (NYSE: BAX) announced that its board of directors has approved the planned separation of its biopharmaceuticals business, which will ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE